Theriva Biologics, Inc. (TOVX) stock
TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.14+0.00 (+2.86%)
Close on Nov 18, 2026Market cap $6.61MP/E –Yield –
Theriva Biologics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Theriva Biologics's market cap was $7.38M on Nov 11, 2026, against $2.78M a year earlier. Over the last 5 years it ranged from $1.21M to $38.29M, with a median of $8.05M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.38M | +240.6% |
| 2025 | Dec 31, 2025 | $2.17M | -52.7% |
| 2024 | Dec 31, 2024 | $4.58M | -37.5% |
| 2023 | Dec 29, 2023 | $7.33M | +1.7% |
| 2022 | Dec 30, 2022 | $7.21M | -80.0% |
| 2021 | Dec 31, 2021 | $35.94M | +372.9% |
| 2020 | Dec 31, 2020 | $7.60M | -11.3% |
| 2019 | Dec 31, 2019 | $8.57M | +186.4% |
| 2018 | Dec 31, 2018 | $2.99M | -95.4% |
| 2017 | Dec 29, 2017 | $65.57M | -5.9% |
| 2016 | Dec 30, 2016 | $69.66M | -66.5% |
| 2015 | Dec 31, 2015 | $207.95M | +143.7% |
| 2014 | Dec 31, 2014 | $85.34M | +24.9% |
| 2013 | Dec 31, 2013 | $68.32M | +16.6% |
| 2012 | Dec 31, 2012 | $58.61M | +64.9% |
| 2011 | Dec 30, 2011 | $35.54M | – |
See a number that looks wrong?